New York Life Investment Management LLC Has $2.03 Million Stock Position in Teleflex Incorporated (NYSE:TFX)

New York Life Investment Management LLC lessened its stake in Teleflex Incorporated (NYSE:TFX) by 4.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,400 shares of the medical technology company’s stock after selling 479 shares during the quarter. New York Life Investment Management LLC’s holdings in Teleflex were worth $2,029,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of TFX. Apollon Wealth Management LLC increased its holdings in shares of Teleflex by 3.7% in the third quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock valued at $377,000 after purchasing an additional 55 shares in the last quarter. SRS Capital Advisors Inc. increased its stake in shares of Teleflex by 0.3% in the 3rd quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock valued at $4,844,000 after buying an additional 60 shares during the period. Janney Montgomery Scott LLC increased its stake in shares of Teleflex by 0.4% in the 3rd quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock valued at $3,792,000 after buying an additional 65 shares during the period. Tokio Marine Asset Management Co. Ltd. raised its position in shares of Teleflex by 4.5% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock worth $375,000 after acquiring an additional 66 shares during the last quarter. Finally, HighTower Advisors LLC lifted its stake in shares of Teleflex by 1.7% during the third quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock valued at $986,000 after acquiring an additional 66 shares during the period. 95.62% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

TFX has been the subject of several recent research reports. Wells Fargo & Company dropped their price objective on Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a report on Friday. Piper Sandler reissued a “neutral” rating and set a $140.00 price target (down from $255.00) on shares of Teleflex in a research note on Friday. Raymond James cut shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday. Truist Financial dropped their target price on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th. Finally, Citizens Jmp downgraded Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday. Nine investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $196.83.

Teleflex Trading Down 4.7 %

Shares of NYSE TFX opened at $132.58 on Monday. Teleflex Incorporated has a twelve month low of $130.60 and a twelve month high of $249.90. The stock has a market cap of $6.16 billion, a price-to-earnings ratio of 26.36, a P/E/G ratio of 1.73 and a beta of 1.16. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The company’s fifty day moving average is $175.44 and its 200-day moving average is $204.65.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million. Equities research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be issued a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 1.03%. Teleflex’s dividend payout ratio (DPR) is currently 95.77%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.